Literature DB >> 26362395

Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice.

Zdenko Pirnik1, Blanka Železná2, Alexander Kiss3, Lenka Maletínská4.   

Abstract

Energy homeostasis is the result of a balance between energy intake and expenditure, and the hypothalamus plays a key role in the regulation of these processes. The hypothalamic prolactin-releasing peptide (PrRP) is involved in food intake regulation and energy homeostasis, although only its lipidized analogs exert central anorexigenic effects after peripheral administration. The aim of the present study was to delineate the extent of the Fos expression as a marker of neuronal activation within the hypothalamic structures involved in food intake regulation after peripherally administered palmitoylated PrRP31 (palm-PrRP31) and to determine whether the anorexigenic effect of peripherally administered palm-PrRP31 influence the activity of hypocretin (HCRT) and oxytocin (OXY) neurons, i.e., the neuropeptides crucially involved in the regulation of energy homeostasis. The data confirmed an anorexigenic effect of palm-PrRP31 treatment (5mg/kg, s.c.) in mice. In the palm-PrRP31-treated animals, a significant increase in Fos expression was observed in the hypothalamic paraventricular (PVN), dorsomedial (DMN), and arcuate (Arc) nuclei and in the neurons of the nucleus of the solitary tract (NTS). Moreover, significant Fos expression was observed in the lateral hypothalamic area (LHA) HCRT neurons and PVN OXY neurons after palm-PrRP31 administration. The present findings may indicate that palm-PrRP31 may be involved in energy homeostasis via the activation of several hypothalamic structures. Fos activation of the hypothalamic OXY and HCRT neurons in the PVN and LHA emphasizes the importance of the areas mentioned in the central action of palm-PrRP31.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fos; Hypocretin; Hypothalamus; Mice; Oxytocin; Prolactin-releasing peptide

Mesh:

Substances:

Year:  2015        PMID: 26362395     DOI: 10.1016/j.brainres.2015.08.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Design of a Long-Acting and Selective MEG-Fatty Acid Stapled Prolactin-Releasing Peptide Analog.

Authors:  Elsa Pflimlin; Sam Lear; Candy Lee; Shan Yu; Huafei Zou; Andrew To; Sean Joseph; Van Nguyen-Tran; Matthew S Tremblay; Weijun Shen
Journal:  ACS Med Chem Lett       Date:  2019-07-05       Impact factor: 4.345

2.  Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.

Authors:  Veronika Pražienková; Martina Holubová; Helena Pelantová; Martina Bugáňová; Zdenko Pirník; Barbora Mikulášková; Andrea Popelová; Miroslava Blechová; Martin Haluzík; Blanka Železná; Marek Kuzma; Jaroslav Kuneš; Lenka Maletínská
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

3.  Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.

Authors:  Z Pirník; L Kořínková; J Osacká; B Železná; J Kuneš; L Maletínská
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

Review 4.  Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.

Authors:  Veronika Pražienková; Andrea Popelová; Jaroslav Kuneš; Lenka Maletínská
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.